Imatinib Completed Phase 2 Trials for Recurrent Gastric Cancer / Stage IV Gastric Cancer Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00068380A Phase II Trial of STI571 in the Treatment of Metastatic Gastric Cancer